Physician profile
Abigail Mitroff
NPI 1457871816
$6,482.64
in general payments reported to CMS, 2019-2025
42 companies · $854 in 2025
The $854 reported for 2025 was more than what 81% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $914 · 2022: $1,523 · 2023: $1,703 · 2024: $1,488 · 2025: $854.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,950 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,949.98 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,578.67 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $510.37 | 2022-2024 | Sotyktu |
| Incyte Corporation | $477.00 | 2022-2025 | Opzelura |
| Lilly USA, LLC | $433.37 | 2021-2025 | Taltz, Ebglyss, Olumiant |
| Janssen Biotech, INC. | $408.70 | 2023-2025 | Tremfya, Stelara, Simponi |
| Astrazeneca Pharmaceuticals LP | $268.84 | 2021-2022 | |
| Genzyme Corporation | $253.68 | 2023-2025 | |
| Novo Nordisk INC | $229.17 | 2021-2022 | |
| Lucid Diagnostics INC. | $206.41 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $174.99 | 2023-2025 | Dupixent |
| Dermavant Sciences, INC. | $158.19 | 2023-2024 | Vtama |
| Glaxosmithkline, LLC. | $153.43 | 2021-2022 | |
| Galderma Laboratories, L.P. | $143.18 | 2023-2025 | Aklief |
| Abbott Laboratories | $134.72 | 2021-2023 | Octrode |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.67 | 2021-2024 | Spevigo |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abigail Mitroff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.